Shire Stock Rising on Takeover Talks
Shire is a biotech company that is focused on serving people with rare diseases and other specialized conditions.

Shares of Shire PLC (SHPG) were gaining by more than 3% to $168.97 on Wednesday, following talk of a takeover of the specialty drug maker.

Some of the largest drug firms in the U.S. and across Europe are said to have hired advisers regarding a move at the Dublin-based company, the Evening Standard reports. Shire is also said to have hired its own defense advisers to ward off low bids.

Shire is a biotech company that is focused on serving people with rare diseases and other specialized conditions.

More of What's Trending on TheStreet:

More from Stocks

Sohn Investing 2018: A Recap

Sohn Investing 2018: A Recap

CHART: Here's How Much Apple Stock Has Lost in Value in the Last Five Days

CHART: Here's How Much Apple Stock Has Lost in Value in the Last Five Days

Wall Street Is Totally Forgetting Apple Will Be Giving Away Tons of Cash in 2018

Wall Street Is Totally Forgetting Apple Will Be Giving Away Tons of Cash in 2018

United Technologies Tops Target on Strong Aerospace Business

United Technologies Tops Target on Strong Aerospace Business

How Did Caterpillar Get Its Name?

How Did Caterpillar Get Its Name?